Portfolio company
TriasBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
TriasBio develops circadian-aware mRNA sequence design software for biotechnology researchers to optimise protein expression timing in therapeutic development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
expressionedits
This company develops a computational platform using artificial intelligence to optimise gene design and enhance protein production for biotechnology and pharmaceutical organisations.
Synthetic biology-powered mRNA therapeutics
The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
Terrain Bio
This company provides machine learning software and manufacturing services for RNA therapeutic sequences to biopharmaceutical research teams.
AtomBioworks
This company develops artificial intelligence software for designing nucleic acids, including mRNA and aptamers, for biotechnology firms and medical research organisations.
Serna Bio
This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
